Envoy Medical appoints Chas McKhann to board of directors
PUBT · 04/16 12:03
Share
Listen to the news
- Envoy Medical appointed Chas McKhann to its board of directors on April 16, 2026.
- McKhann most recently served as CEO of Silk Road Medical, which sold to Boston Scientific for USD 1.16 billion.
- He also led Apollo Endosurgery as CEO before its sale to Boston Scientific for about USD 615 million.
- McKhann will join Envoy Medical compensation committee.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202604160800NEWSFILECNPR____20260416_292772_1) on April 16, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved